A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis

• প্রধান লেখক: Daniel J. Lovell (লেখক), Jason A. Dare (লেখক), Megan Francis-Sedlak (লেখক), Julie Ball (লেখক), Brian D. LaMoreaux (লেখক), Emily Von Scheven (লেখক), Adam Reinhardt (লেখক), Rita Jerath (লেখক), Oral Alpan (লেখক), Ramesh Gupta (লেখক), Donald Goldsmith (লেখক), Andrew Zeft (লেখক), Henry Naddaf (লেখক), Beth Gottlieb (লেখক), Lawrence Jung (লেখক), Robert J. Holt (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: BMC, 2018-06-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Abstract Background Juvenile idiopathic arthritis (JIA) is an inflammatory arthritis of unknown etiology, which lasts for greater than 6 weeks with onset before 16 years of age. JIA is the most common chronic rheumatic disease in children. NSAIDs have been the mainstay of initial management with nap...